Patents by Inventor Betty C. Soliven

Betty C. Soliven has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of inflammatory diseases
    Patent number: 9370497
    Abstract: The present invention relates generally to the field of inflammatory diseases of the peripheral nervous system. More particularly, it concerns methods for treating inflammatory diseases of the peripheral nervous system by modulating sphingosine-1-phosphate receptor activity. In one embodiment, the present invention provides a method of treating a subject with chronic inflammatory demyelinating polyneuropathy (CIDP) or other autoimmune neuropathies comprising administering to the subject an effective amount of FTY720.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: June 21, 2016
    Assignee: The University of Chicago
    Inventor: Betty C. Soliven
  • TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20150335666
    Abstract: The present invention relates generally to the field of inflammatory diseases of the peripheral nervous system. More particularly, it concerns methods for treating inflammatory diseases of the peripheral nervous system by modulating sphingosine-1-phosphate receptor activity. In one embodiment, the present invention provides a method of treating a subject with chronic inflammatory demyelinating polyneuropathy (CIDP) or other autoimmune neuropathies comprising administering to the subject an effective amount of FTY720.
    Type: Application
    Filed: August 5, 2015
    Publication date: November 26, 2015
    Applicant: THE UNIVERSITY OF CHICAGO
    Inventor: Betty C. Soliven
  • Treatment of inflammatory diseases
    Patent number: 9101576
    Abstract: The present invention relates generally to the field of inflammatory diseases of the peripheral nervous system. More particularly, it concerns methods for treating inflammatory diseases of the peripheral nervous system by modulating sphingosine-1-phosphate receptor activity. In one embodiment, the present invention provides a method of treating a subject with chronic inflammatory demyelinating polyneuropathy (CIDP) or other autoimmune neuropathies comprising administering to the subject an effective amount of FTY720.
    Type: Grant
    Filed: August 6, 2012
    Date of Patent: August 11, 2015
    Assignee: The University of Chicago
    Inventor: Betty C. Soliven
  • TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20130017190
    Abstract: The present invention relates generally to the field of inflammatory diseases of the peripheral nervous system. More particularly, it concerns methods for treating inflammatory diseases of the peripheral nervous system by modulating sphingosine-1-phosphate receptor activity. In one embodiment, the present invention provides a method of treating a subject with chronic inflammatory demyelinating polyneuropathy (CIDP) or other autoimmune neuropathies comprising administering to the subject an effective amount of FTY720.
    Type: Application
    Filed: August 6, 2012
    Publication date: January 17, 2013
    Inventor: Betty C. Soliven
  • Treatment of inflammatory diseases
    Patent number: 8258150
    Abstract: The present invention relates generally to the field of inflammatory diseases of the peripheral nervous system. More particularly, it concerns methods for treating inflammatory diseases of the peripheral nervous system by modulating sphingosine-1-phosphate receptor activity. In one embodiment, the present invention provides a method of treating a subject with chronic inflammatory demyelinating polyneuropathy (CIDP) or other autoimmune neuropathies comprising administering to the subject an effective amount of FTY720.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: September 4, 2012
    Assignee: The University of Chicago
    Inventor: Betty C. Soliven
  • Treatment of Inflammatory Diseases
    Publication number: 20100310547
    Abstract: The present invention relates generally to the field of inflammatory diseases of the peripheral nervous system. More particularly, it concerns methods for treating inflammatory diseases of the peripheral nervous system by modulating sphingosine-1-phosphate receptor activity. In one embodiment, the present invention provides a method of treating a subject with chronic inflammatory demyelinating polyneuropathy (CIDP) or other autoimmune neuropathies comprising administering to the subject an effective amount of FTY720.
    Type: Application
    Filed: August 17, 2007
    Publication date: December 9, 2010
    Inventor: Betty C. Soliven